In combination with the autophagy activator, Rap, it was found that the ROS level in silenced ORMDL3 liver cancer cells was reduced (Fig. 4B), indicating that silencing ORMDL3 made the level of ROS in liver cancer cells to increase by inhibiting autophagy. Here, LRPAP1 is linked to liver cancer.